Trials · 2014 · 32 citations · 15 references
NursingPharmacologyPharmacotherapyClinical PharmacologyPain ManagementPain MedicineAnalgesiaAnalgesic PharmacologyPain MeasurementPharmacologic Pain TherapySore Throat ManagementSwallowing AssessmentAnalgesic Effectiveness EvaluationAssessment Of Throat PainClinical Trials Of AnalgesicsDose AssessmentDose SafetyDouble-blind TrialsEvaluation Of PharyngitisThroat Symptom Assessment
BACKGROUND: The sore throat pain model has been conducted by different clinical investigators to demonstrate the efficacy of acute analgesic drugs in single-dose randomized clinical trials. The model used here was designed to study the multiple-dose safety and efficacy of lozenges containing flurbiprofen at 8.75 mg. METHODS: Adults (n=198) with moderate or severe acute sore throat and findings of pharyngitis on a Tonsillo-Pharyngitis Assessment (TPA) were randomly assigned to use either flurbiprofen 8.75 mg lozenges (n=101) or matching placebo lozenges (n=97) under double-blind conditions. Patients sucked one lozenge every three to six hours as needed, up to five lozenges per day, and rated symptoms on 100-mm scales: the Sore Throat Pain Intensity Scale (STPIS), the Difficulty Swallowing Scale (DSS), and the Swollen Throat Scale (SwoTS). RESULTS: Reductions in pain (lasting for three hours) and in difficulty swallowing and throat swelling (for four hours) were observed after a single dose of the flurbiprofen 8.75 mg lozenge (P<0.05 compared with placebo). After using multiple doses over 24 hours, flurbiprofen-treated patients experienced a 59% greater reduction in throat pain, 45% less difficulty swallowing, and 44% less throat swelling than placebo-treated patients (all P<0.01). There were no serious adverse events. CONCLUSIONS: Utilizing the sore throat pain model with multiple doses over 24 hours, flurbiprofen 8.75 mg lozenges were shown to be an effective, well-tolerated treatment for sore throat pain. Other pharmacologic actions (reduced difficulty swallowing and reduced throat swelling) and overall patient satisfaction from the flurbiprofen lozenges were also demonstrated in this multiple-dose implementation of the sore throat pain model. TRIAL REGISTRATION: This trial was registered with ClinicalTrials.gov, registration number: NCT01048866, registration date: January 13, 2010.
15
Mark J. Atkinson, Ritesh Kumar, Joseph C. Cappelleri et al. · Value in Health · 2005 · 347 citations · Full text
Sore throat pain in the evaluation of mild analgesics
Bernard Schachtel, John M. Fillingim, William R. Thoden et al. · Clinical Pharmacology & Therapeutics · 1988 · 89 citations
Caffeine as an Analgesic Adjuvant
Bernard Schachtel · Archives of Internal Medicine · 1991 · 64 citations